Skip to content

Clinical trials

Blood Coagulation Disorders trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blood Coagulation Disorders Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20183
20204
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical4
Seoul National University Bundang Hospital4
Genzyme, a Sanofi Company2
Konkuk University Medical Center1
Seoul National University Hospital1
TiumBio Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blood Coagulation Disorders13
Hemophilia A7
Blood Coagulation Disorders, Inherited6
Coagulation Protein Disorders6
Genetic Diseases, Inborn6
Hematologic Diseases6
Hemorrhagic Disorders6
Hemostatic Disorders4
Hemophilia B3
Genetic Diseases, X-Linked2

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.